The current invention relates to methods for diagnosing and monitoring the progression of a dementia-related neurodegenerative disease in a patient suspected of having such a disease by determining the levels of at least one cell adhesion molecule. The current invention also relates to an antibody directed toward neural cell adhesion molecule.
METHODS FOR DIAGNOSING DEMENTIA-RELATED NEUROLOGICAL DISORDERS